Donor immune cells show promise against Virus-Linked cancers

This study tests whether specially trained immune cells from healthy donors can safely fight cancers and diseases caused by the Epstein-Barr virus (EBV). The cells are made quickly in the lab and stored in a bank, so they are ready for patients whose cancer has returned or not responded to standard treatments. The trial includes 38 people with EBV-positive lymphomas, nasopharyngeal carcinoma, smooth muscle tumors, or severe chronic active EBV. The main goal is to check safety and see if the cells shrink tumors or control the virus.